| |
 |
|
Class Information
Number: 435/455
Name: Chemistry: molecular biology and microbiology > Process of mutation, cell fusion, or genetic modification > Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within an animal cell
Description: Processes of inserting polynucleotide molecules into or rearranging genetic material within an animal cell.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 435/467 |
Introducing an oncogene to establish a cell line |
71 |
| 435/465 |
Involving co-transfection |
189 |
| 435/461 |
Involving electroporation |
117 |
| 435/464 |
Involving gene duplication within the cell (e.g., amplification, co-amplification, etc.) |
51 |
| 435/463 |
Involving general or homologous recombination (e.g., gene targeting, etc.) |
283 |
| 435/460 |
Involving laser treatment of the cell before or during transfection |
16 |
| 435/459 |
Involving particle-mediated transfection (i.e., biolistic transfection) |
80 |
| 435/462 |
Involving site-specific recombination (e.g., cre-lox, etc.) |
143 |
| 435/466 |
The polynucleotide is a shuttle vector or a transiently replicating hybrid vector |
84 |
| 435/458 |
The polynucleotide is coated with or encapsulated within a lipid containing material (e.g., liposome, etc.) |
386 |
| 435/456 |
The polynucleotide is encapsidated within a virus or viral coat |
835 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7615374 |
Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions |
Nov. 10, 2009 |
| 7612046 |
Method for treating kidney disorders |
Nov. 3, 2009 |
| 7611851 |
Canis sphingosine 1-phosphate receptor isoform 1 |
Nov. 3, 2009 |
| 7608431 |
Fed-batch process for production of erythropoietin in human embryonic retina cells that express adenovirus E1A |
Oct. 27, 2009 |
| 7608425 |
Methods for protein expression in mammalian cells in serum-free medium |
Oct. 27, 2009 |
| 7608422 |
Simian immunodeficiency virus (SIV) molecular clone encoding mutant gag gene lacking inhibitory/instability regions |
Oct. 27, 2009 |
| 7604995 |
Compositions, kits, and methods for stimulation of homologous recombination |
Oct. 20, 2009 |
| 7604994 |
Genetically altered antibody-producing cell lines with improved antibody characteristics |
Oct. 20, 2009 |
| 7604960 |
Transient protein expression methods |
Oct. 20, 2009 |
| 7604803 |
Method to enhance an immune response of nucleic acid vaccination |
Oct. 20, 2009 |
| 7601687 |
Mechanism for identifying drugs for the treatment of type II diabetes |
Oct. 13, 2009 |
| 7601345 |
Lentivirus vectors for gene transfer to alveolar epithelial cells |
Oct. 13, 2009 |
| RE40930 |
Porcine adenovirus type 3 genome |
Oct. 6, 2009 |
| 7598078 |
Settings for recombinant adenoviral-based vaccines |
Oct. 6, 2009 |
| 7598077 |
Compositions and methods for enhancing differential expression |
Oct. 6, 2009 |
| 7595193 |
Propagation and/or derivation of embryonic stem cells |
Sep. 29, 2009 |
| 7595187 |
Elaiophylin biosynthetic gene cluster |
Sep. 29, 2009 |
| 7592504 |
Methods for determining specificity of RNA silencing and for genetic analysis of the silenced gene or protein |
Sep. 22, 2009 |
| 7592502 |
Knock-in non-human animal producing human tissue factor |
Sep. 22, 2009 |
| 7592319 |
Uses of DNA-PK |
Sep. 22, 2009 |
| 7592317 |
Constitutive gene expression in conjuction with ionizing radiation |
Sep. 22, 2009 |
| 7592174 |
Isolation of mesenchymal stem cells |
Sep. 22, 2009 |
| 7589258 |
Plant farnesyltransferases |
Sep. 15, 2009 |
| 7588915 |
Isolated genomic polynucleotide fragments from chromosome 7 |
Sep. 15, 2009 |
| 7585960 |
Nucleic acids encoding superagonistic anti-CD28 antibodies |
Sep. 8, 2009 |
| 7585676 |
Retroviral vector |
Sep. 8, 2009 |
| 7585675 |
Inhibition of HIV and SHIV replication with antisense interleukin-4 |
Sep. 8, 2009 |
| 7585666 |
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
Sep. 8, 2009 |
| 7585636 |
Protein subcellular localization assays using split fluorescent proteins |
Sep. 8, 2009 |
| 7585623 |
Adiponectin promoter and use thereof |
Sep. 8, 2009 |
| 7585622 |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
Sep. 8, 2009 |
| 7585498 |
Regulation of adenovirus DNA packaging by IPTG |
Sep. 8, 2009 |
| 7582741 |
Conditional disruption of dicer1 in cell lines and non-human mammals |
Sep. 1, 2009 |
| 7582613 |
Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
Sep. 1, 2009 |
| 7582475 |
Vectors and methods for high throughput co-expression |
Sep. 1, 2009 |
| 7579330 |
Methods of treating various cancers using melanoma differentiation associated protein-7 |
Aug. 25, 2009 |
| 7575896 |
Cell fusion method |
Aug. 18, 2009 |
| 7575752 |
Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
Aug. 18, 2009 |
| 7572633 |
Use of the adenoviral E2 late promoter |
Aug. 11, 2009 |
| 7572438 |
Mutant having uracil phosphoribosyl transferase activity |
Aug. 11, 2009 |
| 7569385 |
Multipotent amniotic fetal stem cells |
Aug. 4, 2009 |
| 7569362 |
Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing |
Aug. 4, 2009 |
| 7569220 |
Compositions and methods for non-targeted activation of endogenous genes |
Aug. 4, 2009 |
| 7569217 |
Porcine adenovirus E1 and E4 regions |
Aug. 4, 2009 |
| 7563881 |
Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus |
Jul. 21, 2009 |
| 7563778 |
Antisense oligonucleotide preparation method |
Jul. 21, 2009 |
| 7563777 |
Method to induce neovascular formation and tissue regeneration |
Jul. 21, 2009 |
| 7563619 |
Mammary stem cell marker |
Jul. 21, 2009 |
| 7560540 |
Nucleic acid encoding dendritic cell co-stimulatory molecules |
Jul. 14, 2009 |
| 7560538 |
Porcine isogloboside 3 synthase protein, cDNA, genomic organization, and regulatory region |
Jul. 14, 2009 |
|
|
|
